Linkage Analysis in Interstitial Cystitis
- Conditions
- Urinary Bladder, OveractivePainful Bladder SyndromeCystitis, InterstitialProstatitisChronic Pelvic Pain Syndrome
- Registration Number
- NCT00675298
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Brief Summary
Urologic pelvic pain syndrome (UCPPS), variably termed painful bladder syndrome/interstitial cystitis (PBS/IC) in females and chronic prostatitis/chronic pelvic pain syndrome in men (CP/CPPS), is a chronic, debilitating clinical syndrome presenting as severe pelvic pain with extreme urinary urgency and frequency in the absence of any known cause. The etiologic mechanisms underlying UCPPS are unknown, but recurrence, risks to siblings of affected individuals, concordance among monozygotic twins, and our own preliminary studies indicate a strong genetic contribution to the cause of UCPPS. The overall goal of this proposal is use novel approaches to understand the basis of UCPPS, to identify candidate genes containing mutations that result in UCPPS and determine how the different encoded proteins of these genes interact with one another in a common biological pathway. Ultimately, understanding how mutations in at least five different genes yield the symptoms of UCPPS should lead to improved diagnosis and possible therapies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
- Have symptoms for at least 3 months within the preceding 6 months:
- Pain in the pelvic area
- Urinary frequency and/or
- Urinary urgency and/or
- Sexual dysfunction (erectile dysfunction)
- Have CP/CPPS, IC, PBS, or BFS
- Be willing to provide a saliva and urine sample
- Agree to complete several brief questionnaires
- Family of someone with CP/CPPS, PBS, IC or BFS
- Live in the USA or Canada
- Major structural/anatomical urinary tract abnormalities
- Underlying inborn or congenital conditions
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Jordan D Dimitrakoff
🇺🇸Boston, Massachusetts, United States